PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 50 mg vial with 2 mL of phosphate-buffered diluent, what concentration do I end up with?

Asked 25 Dec 2025Modified 4 months agoViewed 6.4k times
10

For reference: 50 mg · 2 mL · phosphate-buffered diluent.

I would like the arithmetic checked rather than the conclusion asserted.

I have deliberately not used an online calculator because I want to be able to check the result.

What is the general form of this calculation?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
shareeditfollowflag
BN
askedbirk_nordahl16k3825 Dec 2025
6Same question, and I got two answers that differ by a factor of ten, so I am watching this. – tare_weight 4 months ago
add a comment

5 Answers

Sorted by votes
10

50 ÷ 2 = 25 mg/mL. Concentration is vial content divided by diluent volume, so 50 mg of peptide in 2 mL of phosphate-buffered diluent gives 25 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.25 mg — 250 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.

Specifically, full dissolution of a well-lyophilised cake should take under a minute with gentle swirling and no agitation. If it takes ten minutes, the cake is either over-dried, partially collapsed, or the peptide has already aggregated.

The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.

Reading a lyophilised cake

AppearanceInterpretationAction
Intact opaque puck, proud of baseCycle ran correctlyProceed
Slumped to one sideShipped before fully dry, or vibrationUsually usable; note it
Glassy translucent filmCollapse above glass transitionTest before use
Melt-back ring at stopperThermal excursion in transitTest before use
No visible cake at allVery low fill, or nothing thereWeigh it; query the supplier

On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
OF
answeredorla_ferriter89k14822 Mar 2026
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
7

This is not exotic. It is just the difference between doing it deliberately and doing it approximately.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

Number of stopper piercings matters less than the gauge doing the piercing.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

Worth saying: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
OF
answeredorla_ferriter89k14811 Mar 2026
5

Before anything else: a kitchen counter with an alcohol wipe is not an aseptic environment, and it is worth being honest about that rather than pretending the procedure is something it is not. What you are doing is reducing bioburden, not achieving sterility.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

If the material arrived warm and it was lyophilised, test it and proceed on the result.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
TH
answeredtyndall_haze38k386 Feb 2026
5Does this change at lower concentrations, or does adsorption start to dominate? – sinead_gaffney 3 months ago
add a comment
4

In practice, sodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

The caveat on all of this is that it assumes the vial contains what the label says.

Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.

shareimprove this answerflag
UM
answeredu100_marks52k3717 Feb 2026
3The arithmetic checks out. I ran the same numbers and got the same result. – h_pergande 5 months ago
4Adding that a fixed-needle syringe loses about a tenth of what a luer one does. – Dr_Malik_Osei 7 months ago
add a comment
4

The dissolution time is a signal — if it is longer than expected, something went wrong in either the lyophilisation or the shipping.

Check the barrel marking, not your memory of it.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.

edited 19 Mar 2026 by tabular_nums — removed a claim I could not source

shareimprove this answerflag
TN
answeredtabular_nums71k4828 Feb 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.